Live IntelligenceFDA Advisory Votes • HPLC Purity Audits • Primary Regulatory Filings
Independent Scientific Journalism • 20 Active Investigative Briefings
Discovery Engine

Search Investigations & Intelligence

Full-text search across primary regulatory records, analytical lab audits, and evidence-led pharmacology guides.

Suggested:
Showing 40 results
Why Oral Peptides Are Hard to DeliverGuide
formulations-and-delivery

Why Oral Peptides Are Hard to Deliver

Pepsin and other enzymes dismantle peptides in the stomach within minutes. While oral semaglutide succeeds due to a specific permeation enhancer, standard capsules deliver negligible systemic exposure. This is the core challenge for any.

By Marc DuboisRead Report →
Aizen Signs $100M AI Peptide DealNews Wire
research

Aizen Signs $100M AI Peptide Deal

Aizen Therapeutics, a San Diego-based AI biotech spun out of Caltech, has entered a multi-program collaboration with an undisclosed public partner. The deal includes upfront funding and up to $100 million in milestone payments per target.

By Marc DuboisRead Report →
Are Peptides Banned by the NCAA? Rules and VerificationGuide
anti-doping

Are Peptides Banned by the NCAA? Rules and Verification

The NCAA explicitly bans peptide hormones, growth factors, and related substances. This prohibition applies year-round. A positive test for BPC-157 or MK-677 results in a minimum one-year loss of eligibility, with very narrow exceptions.

By Darius BennettRead Report →
Custom Peptide Synthesis: Process and Quality ControlsGuide
synthesis-and-manufacturing

Custom Peptide Synthesis: Process and Quality Controls

Custom peptide synthesis uses solid-phase synthesis to construct user-defined sequences. Chemists verify each step via in-process testing, while post-synthesis quality control uses mass spectrometry and HPLC to confirm purity tiers.

By Marc DuboisRead Report →
FDA-Approved Peptides: What Approval Actually MeansGuide
approval-and-legality

FDA-Approved Peptides: What Approval Actually Means

While semaglutide and insulin are approved drugs with validated safety data, peptides like BPC-157 and TB-500 are not. Understanding the difference between drug approval and compounding eligibility is critical for patient safety.

By Maya ChenRead Report →
FDA Panel Backs Compounding of Four Unapproved PeptidesNews Wire
regulation

FDA Panel Backs Compounding of Four Unapproved Peptides

An FDA advisory panel narrowly recommended reclassifying four unapproved peptides from a prohibited-compounding category to one that permits licensed pharmacies to prepare them. The vote does not constitute drug approval, and formal.

By Maya ChenRead Report →
Decoding Purity Claims in Research Peptide COAsGuide
purity-and-coa

Decoding Purity Claims in Research Peptide COAs

A purity percentage on a label is not evidence; it is a claim. High-purity research peptides require verification via third-party Certificates of Analysis (COAs) that detail HPLC and mass spectrometry results. This reference explains how.

By Marc DuboisRead Report →
Peptide Testing: Identity, Purity, and Analytical LimitsGuide
analytical-testing

Peptide Testing: Identity, Purity, and Analytical Limits

Peptide testing is not a single assay but a multi-modal verification process. This guide distinguishes between identity confirmation, chromatographic purity, and quantitative content, detailing how mass spectrometry and HPLC function.

By Marc DuboisRead Report →